These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 25805753)

  • 1. Lack of Galectin-3 Prevents Cardiac Fibrosis and Effective Immune Responses in a Murine Model of Trypanosoma cruzi Infection.
    Pineda MA; Cuervo H; Fresno M; Soto M; Bonay P
    J Infect Dis; 2015 Oct; 212(7):1160-71. PubMed ID: 25805753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3: A Friend but Not a Foe during
    da Silva AA; Teixeira TL; Teixeira SC; Machado FC; Dos Santos MA; Tomiosso TC; Tavares PCB; Brígido RTES; Martins FA; Silva NSL; Rodrigues CC; Roque-Barreira MC; Mortara RA; Lopes DS; Ávila VMR; da Silva CV
    Front Cell Infect Microbiol; 2017; 7():463. PubMed ID: 29164071
    [No Abstract]   [Full Text] [Related]  

  • 3. Galectin-3 and Chagas Disease-Associated Cardiomyopathy.
    Novaes RD; Gonçalves RV; Caldas IS
    J Infect Dis; 2016 Mar; 213(5):871. PubMed ID: 26464205
    [No Abstract]   [Full Text] [Related]  

  • 4. A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection.
    Barry MA; Versteeg L; Wang Q; Pollet J; Zhan B; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007413. PubMed ID: 31145733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells.
    Benatar AF; García GA; Bua J; Cerliani JP; Postan M; Tasso LM; Scaglione J; Stupirski JC; Toscano MA; Rabinovich GA; Gómez KA
    PLoS Negl Trop Dis; 2015; 9(10):e0004148. PubMed ID: 26451839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.
    Pellegrini A; Guiñazu N; Giordanengo L; Cano RC; Gea S
    Future Microbiol; 2011 Dec; 6(12):1521-33. PubMed ID: 22122446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi cleaves galectin-3 N-terminal domain to suppress its innate microbicidal activity.
    Pineda M; Corvo L; Callejas-Hernández F; Fresno M; Bonay P
    Clin Exp Immunol; 2020 Feb; 199(2):216-229. PubMed ID: 31593356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 mediates survival and apoptosis pathways during Trypanosoma cruzi-host cell interplay.
    Chain MO; Paiva CAM; Maciel IO; Neto AN; Castro VF; Oliveira CP; Mendonça BDS; Nestal de Moraes G; Reis SAD; Carvalho MA; De-Melo LDB
    Exp Parasitol; 2020 Sep; 216():107932. PubMed ID: 32535113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose Tissue-Derived Mesenchymal Stromal Cells Protect Mice Infected with Trypanosoma cruzi from Cardiac Damage through Modulation of Anti-parasite Immunity.
    Mello DB; Ramos IP; Mesquita FC; Brasil GV; Rocha NN; Takiya CM; Lima AP; Campos de Carvalho AC; Goldenberg RS; Carvalho AB
    PLoS Negl Trop Dis; 2015; 9(8):e0003945. PubMed ID: 26248209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed Cell Death Protein 1-PDL1 Interaction Prevents Heart Damage in Chronic
    Fonseca R; Salgado RM; Borges da Silva H; do Nascimento RS; D'Império-Lima MR; Alvarez JM
    Front Immunol; 2018; 9():997. PubMed ID: 29867974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy.
    Vasconcelos JF; Souza BS; Lins TF; Garcia LM; Kaneto CM; Sampaio GP; de Alcântara AC; Meira CS; Macambira SG; Ribeiro-dos-Santos R; Soares MB
    FASEB J; 2013 Dec; 27(12):4691-702. PubMed ID: 23964077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor Slamf1 on the surface of myeloid lineage cells controls susceptibility to infection by Trypanosoma cruzi.
    Calderón J; Maganto-Garcia E; Punzón C; Carrión J; Terhorst C; Fresno M
    PLoS Pathog; 2012; 8(7):e1002799. PubMed ID: 22807679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi.
    Tarleton RL; Grusby MJ; Zhang L
    J Immunol; 2000 Aug; 165(3):1520-5. PubMed ID: 10903759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to Novaes et al.
    Bonay P; Pineda MA
    J Infect Dis; 2016 Mar; 213(5):871-3. PubMed ID: 26464203
    [No Abstract]   [Full Text] [Related]  

  • 16. Innate and acquired immunity in the pathogenesis of Chagas disease.
    Golgher D; Gazzinelli RT
    Autoimmunity; 2004 Aug; 37(5):399-409. PubMed ID: 15621564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory role of Toll-like receptor 2 during infection with Trypanosoma cruzi.
    Ropert C; Gazzinelli RT
    J Endotoxin Res; 2004; 10(6):425-30. PubMed ID: 15588426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent Mechanisms.
    Poncini CV; Ilarregui JM; Batalla EI; Engels S; Cerliani JP; Cucher MA; van Kooyk Y; González-Cappa SM; Rabinovich GA
    J Immunol; 2015 Oct; 195(7):3311-24. PubMed ID: 26324777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR-dependent induction of IFN-beta mediates host defense against Trypanosoma cruzi.
    Koga R; Hamano S; Kuwata H; Atarashi K; Ogawa M; Hisaeda H; Yamamoto M; Akira S; Himeno K; Matsumoto M; Takeda K
    J Immunol; 2006 Nov; 177(10):7059-66. PubMed ID: 17082622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
    Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
    Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.